Evidence map›Paper›PMID 31929891›Full record

ArticleMolecular and clinical oncology2020

Alarming endoscopic data in young and older asymptomatic people: Results of an open access, unlimited age colonoscopic screening for colorectal cancer.

Vasileios Panteris, Nikolaos Vasilakis, Maria Demonakou, Eleni Kornarou, Eftyxios Ktenas, Emanuella Rapti, George Spithakis, Konstantina Katopodi, Maria Horti, Stefani Vgenopoulou and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. From the Friend to the Foe-International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Vasileios PanterisDepartment of Gastroenterology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Nikolaos VasilakisDepartment of Gastroenterology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Maria DemonakouDepartment of Histopathology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Eleni KornarouDepartment of Epidemiology and Biostatistics, National School of Public Health, 11521 Athens, Greece.
Eftyxios KtenasDepartment of Epidemiology and Biostatistics, National School of Public Health, 11521 Athens, Greece.
Emanuella RaptiDepartment of Gastroenterology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
George SpithakisDepartment of Gastroenterology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Konstantina KatopodiDepartment of Gastroenterology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Maria HortiDepartment of Histopathology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Stefani VgenopoulouDepartment of Histopathology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
John TriantafyllidisDepartment of Gastroenterology, Metropolitan General, Hellenic Society of Gastrointestinal Oncology, 15562 Athens, Greece.
Apostolos PapaloisExperimental, Educational and Research Center, ELPEN Laboratories, Hellenic Society of Gastrointestinal Oncology, 19009 Athens, Greece.
Panagiotis KarantanosDepartment of Gastroenterology, Sismanogleio-Amalia Flemig General Hospital, 15126 Athens, Greece.
Sismanoglio General Hospital · GRNational School of Public Health · GRSenologic Hellenic Society · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a lack of a national organized screening program for colorectal cancer in Greece, and asymptomatic detection is usually the result of individual decisions. The collection of epidemiologic endoscopic data from a population of interest would therefore provide valuable information for future treatment guidance, especially during periods of economic austerity. The current cross-sectional study included 380 asymptomatic, average risk individuals undergoing screening colonoscopy for the first time, during the period of one year in a tertiary public hospital in Athens. Descriptive and analytic epidemiologic data were analyzed. The prevalence of adenomas and advanced lesions were compared between the younger and older cohort, and a regression model was applied for risk evaluation. The mean age of participants was 63 years, and 53% were male. A significant proportion of patients presented with polyps (51.5%) and 25% of them had lesions in the proximal colon. The prevalence of adenomas and advanced adenomas was 29.5 and 11.8%, respectively. Similar high prevalence rates of lesions were identified in the cohort of individuals <50 years of age and the older cohort (>50 years of age). Regression models identified age, number and size of polyps as the major risk factors for the detection of adenomas. The increase of advanced lesions in the older and younger cohort requires confirmation by larger studies. Overall, the results of the present study indicate the requirement for a well-organized screening colonoscopy program starting from as early as 40 years of age. This program may confer an additional endoscopic burden with socioeconomic consequences in a country with limited health resources.

Indexed as

colonoscopycolorectal cancerpublic healthscreening

Identifiers

PMID31929891
PMCPMC6951112
OpenAlexW2994755916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.